Genomic characterization of circulating influenza type-A viruses (IAVs) directs the selection
of appropriate vaccine formulations and early detection of potentially pandemic virus strains …

Background Acute lower respiratory infection (ALRI) remains the leading cause of death in
children worldwide, and viruses have been the major cause of ALRI. In Myanmar, ALRI is …

Eradicating influenza A virus (IAV) is difficult, due to its genetic drift and reassortment ability.
As the infectious cycle is initiated by the influenza glycoprotein, hemagglutinin (HA), which …

This study aimed to analyze the genetic and evolutionary characteristics of the influenza
A/H3N2 viruses circulating in Myanmar from 2015 to 2019. Whole genomes from 79 virus …

Background Influenza caused by the H1N1 virus still affects human health. There is currently
no effective strategy against H1N1 virus infection. The present study is to evaluate the …

Madin-Darby canine kidney (MDCK) cells are widely used in basic research and for the
propagation of influenza A viruses (IAV) for vaccine production. To identify targets for …

An influenza circulation was observed in Myanmar between October and November in 2021.
Patients with symptoms of influenza-like illness were screened using rapid diagnostic test …

Abstract Background Influenza A virus (IAV) remains an important global public health threat
with limited epidemiological information available from low-and-middle-income countries …

Background: The rapid mutation of the H1N1 strain of the Influenza virus makes it quite
difficult to treat once the infection has spread. The development of new treatments based on …

Baloxavir marboxil has been used for influenza treatment since March 2018 in Japan. After
baloxavir treatment, the most frequently detected substitution is Ile38Thr in polymerase …